LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner
Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epitheliu...
Saved in:
Published in | Journal of hematology and oncology Vol. 9; no. 1; p. 117 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
03.11.2016
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression.
In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging.
We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H
O
and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4.
Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA. |
---|---|
AbstractList | Abstract Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. Methods In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. Results We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Conclusions Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA. Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. Methods In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. Results We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Conclusions Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA. BACKGROUNDLong non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression.METHODSIn this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging.RESULTSWe firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H2O2 and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4.CONCLUSIONSOur study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA. Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in cholangiocarcinoma (CCA), a cholangiocyte malignancy with poor prognosis, associated with chronic inflammation and damage to the biliary epithelium. The aim of the study is to identify if any lncRNA might associate with inflammation or oxidative stress in CCA and regulate the disease progression. In this study, RNA-seqs datasets were used to identify aberrantly expressed lncRNAs. Small interfering RNA and overexpressed plasmids were used to modulate the expression of lncRNAs, and luciferase target assay RNA immunoprecipitation (RIP) was performed to explore the mechanism of miRNA-lncRNA sponging. We firstly analyzed five available RNA-seqs datasets to investigate aberrantly expressed lncRNAs which might associate with inflammation or oxidative stress. We identified that two lncRNAs, H19 and HULC, were differentially expressed among all the samples under the treatment of hypoxic or inflammatory factors, and they were shown to be stimulated by short-term oxidative stress responses to H O and glucose oxidase in CCA cell lines. Further studies revealed that these two lncRNAs promoted cholangiocyte migration and invasion via the inflammation pathway. H19 and HULC functioned as competing endogenous RNAs (ceRNAs) by sponging let-7a/let-7b and miR-372/miR-373, respectively, which activate pivotal inflammation cytokine IL-6 and chemokine receptor CXCR4. Our study revealed that H19 and HULC, up-regulated by oxidative stress, regulate CCA cell migration and invasion by targeting IL-6 and CXCR4 via ceRNA patterns of sponging let-7a/let-7b and miR-372/miR-373, respectively. The results suggest that these lncRNAs might be the chief culprits of CCA pathogenesis and progression. The study provides new insight into the mechanism linking lncRNA function with CCA and may serve as novel targets for the development of new countermeasures of CCA. |
ArticleNumber | 117 |
Author | Wei, Pan-Pan Wang, Wen-Tao Ye, Hua Han, Bo-Wei He, Bo Chen, Yue-Qin Chen, Zhen- Hua |
Author_xml | – sequence: 1 givenname: Wen-Tao surname: Wang fullname: Wang, Wen-Tao – sequence: 2 givenname: Hua surname: Ye fullname: Ye, Hua – sequence: 3 givenname: Pan-Pan surname: Wei fullname: Wei, Pan-Pan – sequence: 4 givenname: Bo-Wei surname: Han fullname: Han, Bo-Wei – sequence: 5 givenname: Bo surname: He fullname: He, Bo – sequence: 6 givenname: Zhen- Hua surname: Chen fullname: Chen, Zhen- Hua – sequence: 7 givenname: Yue-Qin surname: Chen fullname: Chen, Yue-Qin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27809873$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAQtVARbRd-ABdkiQuHBmzH-fAFqVrRbqUVSIierYljZ71K7MVOVu0P4H_j7Jaq7QHJX-N573k8M-foxHmnEXpPyWdK6_JLpDnhRUZomZGc1xl5hc5oVZRZXTF28uR8is5j3BJSUsHIG3TKqpqIusrP0J-1Uz-_X0a8ogKDa_Hqdr28wKBGu4dRt7i5x_7OtpBsjeMYdIwXeBf84EeNle57PNguJLd3B751e4izYR1WG9-D66xXEJR1fgA8boKfug2GxE3v4gGc0-Etem2gj_rdw75At1fffi1X2frH9c3ycp2pkokxM0XL0jBtYYxKH9aKE1BVwXjV5IQYDoxSZfLWlIqUShnRABWKz9OIRFmgm6Nu62Erd8EOEO6lBysPFz50EsJoVa8lMa1mlW6J4IYLThsgIteaNoazvNF10vp61NpNzaBbpd0YoH8m-tzj7EZ2fi-LJCTKIgl8ehAI_vek4ygHG-eMgtN-ipLWeVkxwUuWoB9fQLd-Ci6l6oBiBSN8Rn14GtFjKP-qnQD0CFDBxxi0eYRQIueOkseOkqmj5NxRaVmg6gVH2fFQ7vQp2_-H-RepUNEq |
CitedBy_id | crossref_primary_10_1080_10408398_2021_2001785 crossref_primary_10_1155_2021_7777699 crossref_primary_10_1016_j_gene_2024_148616 crossref_primary_10_3892_wasj_2019_18 crossref_primary_10_3390_ncrna8060072 crossref_primary_10_3892_ijmm_2018_3457 crossref_primary_10_1155_2020_3035624 crossref_primary_10_1080_15384101_2019_1593647 crossref_primary_10_1007_s00011_017_1035_5 crossref_primary_10_1016_j_omtn_2019_11_031 crossref_primary_10_1016_j_omtn_2019_11_028 crossref_primary_10_1186_s12943_018_0879_9 crossref_primary_10_1080_15376516_2023_2197489 crossref_primary_10_1186_s12964_018_0271_9 crossref_primary_10_1016_j_biopha_2020_109916 crossref_primary_10_1093_bfgp_elaa026 crossref_primary_10_1089_ars_2017_7276 crossref_primary_10_1186_s12920_018_0465_4 crossref_primary_10_3390_ncrna9020019 crossref_primary_10_1016_j_biopha_2020_110228 crossref_primary_10_1016_j_omtn_2018_04_001 crossref_primary_10_1016_j_genrep_2023_101790 crossref_primary_10_3390_cells10081892 crossref_primary_10_1016_j_jdermsci_2020_03_002 crossref_primary_10_1080_07391102_2022_2068650 crossref_primary_10_1080_21691401_2019_1669618 crossref_primary_10_1016_j_omtn_2020_06_025 crossref_primary_10_1111_jcmm_15088 crossref_primary_10_3390_antiox13010028 crossref_primary_10_3892_etm_2019_8052 crossref_primary_10_1016_j_ijbiomac_2024_137248 crossref_primary_10_1002_jcb_26217 crossref_primary_10_1016_j_omtn_2018_10_001 crossref_primary_10_18632_aging_202446 crossref_primary_10_1089_ars_2023_0253 crossref_primary_10_1016_j_yjmcc_2019_04_004 crossref_primary_10_1016_j_biopha_2019_109607 crossref_primary_10_1080_02713683_2021_2021586 crossref_primary_10_23950_jcmk_12662 crossref_primary_10_18632_oncotarget_23325 crossref_primary_10_3390_cancers16244239 crossref_primary_10_1007_s12015_022_10327_x crossref_primary_10_1016_j_gene_2017_12_017 crossref_primary_10_3390_nu14214503 crossref_primary_10_3389_fmed_2020_00048 crossref_primary_10_18632_aging_203903 crossref_primary_10_1186_s43556_020_00004_1 crossref_primary_10_1038_s41419_019_1694_y crossref_primary_10_1186_s13018_023_04003_0 crossref_primary_10_1093_nar_gkaa1017 crossref_primary_10_3748_wjg_v25_i35_5283 crossref_primary_10_1002_kjm2_12191 crossref_primary_10_1016_j_ncrna_2024_06_007 crossref_primary_10_1111_jgh_15657 crossref_primary_10_1186_s12645_023_00183_w crossref_primary_10_1080_10408398_2021_2020720 crossref_primary_10_1002_jcp_29765 crossref_primary_10_1016_j_trsl_2020_05_010 crossref_primary_10_18632_oncotarget_19502 crossref_primary_10_1042_BCJ20200219 crossref_primary_10_1002_mc_23358 crossref_primary_10_3390_cells11152277 crossref_primary_10_1002_mgg3_1125 crossref_primary_10_1016_j_gene_2018_03_027 crossref_primary_10_3390_antiox9060468 crossref_primary_10_1002_jcp_28450 crossref_primary_10_1038_s41419_018_0282_x crossref_primary_10_1272_jnms_JNMS_2018_86_402 crossref_primary_10_1177_1535370218804781 crossref_primary_10_3390_biomedicines10051212 crossref_primary_10_3892_ijo_2020_5047 crossref_primary_10_1016_j_neuroscience_2020_04_020 crossref_primary_10_1002_jcb_26273 crossref_primary_10_1016_j_prp_2024_155223 crossref_primary_10_1016_j_molimm_2018_11_011 crossref_primary_10_1002_jcp_27915 crossref_primary_10_1093_abbs_gmx048 crossref_primary_10_18632_aging_101999 crossref_primary_10_1080_08927022_2022_2055012 crossref_primary_10_3390_cells13231935 crossref_primary_10_1016_j_bbrc_2018_11_185 crossref_primary_10_1089_bio_2020_0088 crossref_primary_10_1016_j_jhep_2021_12_014 crossref_primary_10_1182_blood_2019000802 crossref_primary_10_1186_s13287_018_0861_x crossref_primary_10_2174_1566524022666220509122505 crossref_primary_10_3389_fonc_2019_00649 crossref_primary_10_1590_1414_431x20198385 crossref_primary_10_3390_cells11060985 crossref_primary_10_1016_j_yexcr_2022_113340 crossref_primary_10_1155_2019_8626703 crossref_primary_10_14814_phy2_70160 crossref_primary_10_3727_096504017X15024935181289 crossref_primary_10_1007_s00018_019_03240_z crossref_primary_10_1016_j_biopha_2019_109774 crossref_primary_10_1042_BSR20200740 crossref_primary_10_1155_2020_6069390 crossref_primary_10_1002_cac2_12109 crossref_primary_10_1089_ars_2017_7229 crossref_primary_10_1016_j_biopha_2018_02_134 crossref_primary_10_1097_MD_0000000000008583 crossref_primary_10_1080_07391102_2022_2103028 crossref_primary_10_1097_CM9_0000000000002722 crossref_primary_10_3390_ijms252212459 crossref_primary_10_1016_j_gene_2018_11_072 crossref_primary_10_1016_j_canlet_2021_08_004 crossref_primary_10_1080_15476286_2018_1493333 crossref_primary_10_3390_jcm9041200 crossref_primary_10_3389_fonc_2020_00285 crossref_primary_10_1111_jphp_13170 crossref_primary_10_1007_s10753_019_00995_2 crossref_primary_10_1016_j_bbadis_2017_06_014 crossref_primary_10_1155_2020_5976127 crossref_primary_10_1186_s13046_018_0994_x crossref_primary_10_1152_ajpcell_00394_2020 crossref_primary_10_1016_j_gene_2018_05_096 crossref_primary_10_1080_15384101_2019_1598726 crossref_primary_10_3390_cells11162517 crossref_primary_10_2147_OTT_S291123 crossref_primary_10_1016_j_biopha_2023_114698 crossref_primary_10_1002_mog2_70000 crossref_primary_10_3390_cancers15174399 crossref_primary_10_1111_liv_14085 crossref_primary_10_4291_wjgp_v12_i5_84 crossref_primary_10_3892_ol_2018_9137 crossref_primary_10_1007_s11033_021_06680_8 crossref_primary_10_3389_fgene_2019_00918 crossref_primary_10_1111_febs_17253 crossref_primary_10_3389_fcell_2022_890605 crossref_primary_10_1016_j_neuroscience_2018_12_040 crossref_primary_10_1002_jcla_23656 crossref_primary_10_1097_SCS_0000000000007824 crossref_primary_10_1016_j_semcancer_2020_10_009 crossref_primary_10_18632_oncotarget_16880 crossref_primary_10_3892_mmr_2022_12878 crossref_primary_10_1016_j_neuroscience_2022_07_028 crossref_primary_10_1111_nyas_13612 crossref_primary_10_1093_abbs_gmx141 crossref_primary_10_3892_mmr_2018_8782 crossref_primary_10_3389_fimmu_2020_579687 crossref_primary_10_3390_cells9122613 crossref_primary_10_3389_fgene_2020_01015 crossref_primary_10_1002_hep_31765 crossref_primary_10_2174_1574892818666221207115016 crossref_primary_10_1111_cpr_12397 crossref_primary_10_1186_s12935_019_0866_2 crossref_primary_10_1371_journal_pone_0260103 crossref_primary_10_3389_fphys_2021_659638 crossref_primary_10_1002_cam4_1721 crossref_primary_10_1016_j_biopha_2018_11_065 crossref_primary_10_1016_j_biopha_2019_109222 crossref_primary_10_1186_s13045_017_0428_9 crossref_primary_10_1111_cas_14447 crossref_primary_10_1016_j_biopha_2018_03_083 crossref_primary_10_31083_j_fbl2808173 crossref_primary_10_3390_cells11010005 crossref_primary_10_3390_ijms26052194 crossref_primary_10_1007_s11605_021_05160_5 crossref_primary_10_1002_jcb_29222 crossref_primary_10_1186_s10020_020_00156_4 crossref_primary_10_1016_j_biopha_2021_111753 crossref_primary_10_1002_jcb_28531 crossref_primary_10_3389_fendo_2023_1238981 crossref_primary_10_1016_j_arcmed_2021_06_009 crossref_primary_10_1155_2019_1318795 crossref_primary_10_1155_2019_2601271 crossref_primary_10_1002_hep_31534 crossref_primary_10_1038_s41598_023_35167_8 crossref_primary_10_1186_s12864_018_5133_8 crossref_primary_10_1111_1440_1681_13283 crossref_primary_10_1080_21655979_2022_2074703 crossref_primary_10_1016_j_biochi_2019_04_006 crossref_primary_10_1152_ajpheart_00681_2024 crossref_primary_10_2217_epi_2018_0182 crossref_primary_10_3389_fcell_2022_838332 |
Cites_doi | 10.1186/s13045-016-0288-8 10.1038/onc.2015.396 10.1007/s00432-008-0483-2 10.1007/s00018-016-2339-2 10.1016/j.freeradbiomed.2013.07.034 10.4049/jimmunol.178.6.3893 10.1016/j.taap.2014.10.022 10.1093/hmg/ddu040 10.1186/s13045-015-0129-1 10.1186/s13045-014-0063-7 10.1186/1471-2164-15-S9-S7 10.1002/ijc.21893 10.1023/A:1018822628096 10.1016/j.canlet.2013.01.033 10.1016/j.freeradbiomed.2010.09.006 10.1016/j.biocel.2014.02.022 10.1186/s13045-014-0090-4 10.1053/j.gastro.2013.10.013 10.1186/s13046-014-0103-8 10.1002/eji.201344126 10.3109/10715762.2016.1172071 10.1073/pnas.1310201110 10.1038/srep24141 10.3748/wjg.v20.i33.11630 10.3748/wjg.v20.i46.17324 10.1155/2012/630543 10.7554/eLife.01776 10.1097/00000658-199803000-00012 10.1093/nar/gkq285 10.1158/0008-5472.CAN-15-1443 10.1016/j.ccell.2015.02.004 10.1186/s12943-015-0458-2 10.1007/s10620-010-1481-1 10.1126/scisignal.6288er5 10.1007/s00408-016-9879-y 10.1186/s13045-015-0146-0 10.1093/carcin/bgh157 10.1038/nature17039 10.1002/hep.24563 10.1159/000430109 10.1016/j.molcel.2013.08.027 10.1074/jbc.M112.342113 10.1097/MOH.0000000000000002 10.1111/j.1600-0625.2011.01359.x 10.1073/pnas.161272598 10.1016/j.cellsig.2013.01.007 10.3748/wjg.v13.i10.1561 10.3748/wjg.v18.i29.3849 10.1111/cpr.12228 10.2353/ajpath.2006.050204 10.1155/2014/149185 10.1038/sj.onc.1210648 10.1016/j.jhep.2008.09.015 10.1152/ajprenal.00290.2015 10.1016/j.parint.2011.06.011 10.1007/s13277-013-0688-0 10.1186/s13073-015-0162-2 10.2174/1381612043384727 10.1515/BC.2006.049 10.1111/j.1742-4658.2012.08694.x 10.1126/science.1251456 10.1186/2050-7771-2-19 |
ContentType | Journal Article |
Copyright | Copyright BioMed Central 2016 The Author(s). 2016 |
Copyright_xml | – notice: Copyright BioMed Central 2016 – notice: The Author(s). 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13045-016-0348-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1756-8722 |
EndPage | 117 |
ExternalDocumentID | oai_doaj_org_article_0fde27ed094f4941ba093ee1bf423be8 PMC5093965 4239632311 27809873 10_1186_s13045_016_0348_0 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US China Japan |
GeographicLocations_xml | – name: China – name: United States--US – name: Japan |
GrantInformation_xml | – fundername: ; grantid: 2014A020212135 and 81270629 |
GroupedDBID | --- 0R~ 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP ~8M -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c629t-f5d25d2fd5ffc348ec40ac75247b300f4a211cf3df6c06ccf9ba19c419c4f9fc3 |
IEDL.DBID | 7X7 |
ISSN | 1756-8722 |
IngestDate | Wed Aug 27 01:30:05 EDT 2025 Thu Aug 21 18:23:37 EDT 2025 Fri Jul 11 06:49:09 EDT 2025 Fri Jul 25 06:49:05 EDT 2025 Thu Jan 02 23:08:22 EST 2025 Tue Jul 01 04:23:11 EDT 2025 Thu Apr 24 23:12:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Oxidative stress ceRNA Migration and invasion Cholangiocarcinoma Inflammation response |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c629t-f5d25d2fd5ffc348ec40ac75247b300f4a211cf3df6c06ccf9ba19c419c4f9fc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/1836252042?pq-origsite=%requestingapplication% |
PMID | 27809873 |
PQID | 1836252042 |
PQPubID | 54946 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0fde27ed094f4941ba093ee1bf423be8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5093965 proquest_miscellaneous_1836729462 proquest_journals_1836252042 pubmed_primary_27809873 crossref_primary_10_1186_s13045_016_0348_0 crossref_citationtrail_10_1186_s13045_016_0348_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-11-03 |
PublicationDateYYYYMMDD | 2016-11-03 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-03 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of hematology and oncology |
PublicationTitleAlternate | J Hematol Oncol |
PublicationYear | 2016 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | Y Liu (348_CR12) 2015; 282 AN Kallen (348_CR39) 2013; 52 FO Carvalho de (348_CR65) 2016; 194 K Leelawat (348_CR53) 2007; 13 H Cui (348_CR10) 2014; 44 S Pinlaor (348_CR3) 2004; 25 P Monnier (348_CR58) 2013; 110 F Yang (348_CR59) 2012; 279 YJ Chen (348_CR19) 2012; 18 A Sanchez-Mejias (348_CR38) 2015; 8 D Uchida (348_CR37) 2016; 50 C Li (348_CR61) 2015; 36 JH Yu (348_CR66) 2014; 20 SY Kim (348_CR48) 2013; 25 K Fang (348_CR43) 2014; 23 E Raveh (348_CR56) 2015; 14 N Namwat (348_CR21) 2012; 13 F Virgilio Di (348_CR62) 2004; 10 R Thanan (348_CR63) 2013; 65 BW Han (348_CR25) 2013; 6 S Reuter (348_CR7) 2010; 49 C Voellenkle (348_CR29) 2016; 6 S Kawanishi (348_CR5) 2006; 387 A Prawan (348_CR67) 2009; 135 AA Yarmishyn (348_CR14) 2014; 15 M Luo (348_CR57) 2013; 333 348_CR64 IJ Matouk (348_CR55) 1843; 2014 HR Rosen (348_CR51) 1997; 42 M Krawczyk (348_CR11) 2014; 3 Y Chen (348_CR18) 2011; 56 KY Lin (348_CR49) 2016; 35 J Wang (348_CR27) 2010; 38 P Wang (348_CR42) 2014; 344 MD Huang (348_CR22) 2015; 8 P Chusorn (348_CR20) 2013; 34 S Pinlaor (348_CR6) 2006; 119 M Tarocchi (348_CR9) 2014; 20 S Rizvi (348_CR4) 2013; 145 J Lin (348_CR33) 2015; 309 G Fava (348_CR1) 2012; 2012 S Hummel (348_CR52) 2014; 21 T Minamino (348_CR35) 2001; 98 C Johnson (348_CR40) 2012; 1 G Landskron (348_CR47) 2014; 2014 N Iizuka (348_CR24) 2004; 24 AH Mirza (348_CR31) 2015; 7 S Zhao (348_CR41) 2014; 33 F Meng (348_CR17) 2008; 27 Y Fan (348_CR45) 2016; 9 TP Xu (348_CR44) 2014; 7 PJ McKiernan (348_CR32) 2014; 52 P Yongvanit (348_CR8) 2012; 61 V Oliveira-Marques de (348_CR34) 2007; 178 S Manca (348_CR13) 2011; 20 JS Goydos (348_CR50) 1998; 227 G Loewen (348_CR23) 2014; 7 Y Du (348_CR60) 2012; 287 M Karin (348_CR2) 2016; 529 G Li (348_CR28) 2014; 2014 PJ Mishra (348_CR16) 2014; 2 F Yang (348_CR26) 2011; 54 L Chen (348_CR15) 2009; 50 S Ohira (348_CR54) 2006; 168 B Liu (348_CR30) 2015; 27 S Kongpetch (348_CR36) 2016; 49 A Eichten (348_CR46) 2016; 76 17621267 - Oncogene. 2008 Jan 10;27(3):378-86 24275689 - Curr Opin Hematol. 2014 Jan;21(1):29-36 27063004 - Sci Rep. 2016 Apr 11;6:24141 21704729 - Parasitol Int. 2012 Mar;61(1):130-5 21994887 - Int J Hepatol. 2012;2012:630543 25759022 - Cancer Cell. 2015 Mar 9;27(3):370-81 25966845 - J Hematol Oncol. 2015 May 14;8:50 24901008 - J Immunol Res. 2014;2014:149185 24055342 - Mol Cell. 2013 Oct 10;52(1):101-12 15736456 - Anticancer Res. 2004 Nov-Dec;24(6):4085-9 26921327 - Cancer Res. 2016 Apr 15;76(8):2327-39 20423907 - Nucleic Acids Res. 2010 Sep;38(16):5366-83 25968300 - Cell Physiol Biochem. 2015;36(2):423-34 17339489 - J Immunol. 2007 Mar 15;178(6):3893-902 25522241 - BMC Genomics. 2014;15 Suppl 9:S7 23917144 - Free Radic Biol Med. 2013 Dec;65:1464-72 26791721 - Nature. 2016 Jan 21;529(7586):307-15 15134562 - Curr Pharm Des. 2004;10(14):1647-52 27439973 - J Hematol Oncol. 2016 Jul 21;9(1):57 25447409 - Toxicol Appl Pharmacol. 2015 Jan 1;282(1):9-19 16570287 - Int J Cancer. 2006 Sep 1;119(5):1067-72 22724089 - Transl Gastrointest Cancer. 2012 Apr 1;1(1):58-70 21913998 - Exp Dermatol. 2011 Nov;20(11):932-7 26536864 - Mol Cancer. 2015 Nov 04;14:184 26400545 - Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F901-13 24488769 - Hum Mol Genet. 2014 Jun 15;23(12):3278-88 11447290 - Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8798-803 27113373 - Lung. 2016 Aug;194(4):487-99 25491133 - J Hematol Oncol. 2014 Dec 10;7:90 26726846 - Cell Prolif. 2016 Feb;49(1):90-101 22776265 - FEBS J. 2012 Sep;279(17):3159-65 25471741 - J Exp Clin Cancer Res. 2014 Dec 04;33:103 22876037 - World J Gastroenterol. 2012 Aug 7;18(29):3849-61 20840865 - Free Radic Biol Med. 2010 Dec 1;49(11):1603-16 25206269 - World J Gastroenterol. 2014 Sep 7;20(33):11630-40 26455324 - Oncogene. 2016 Jun 30;35(26):3376-86 24757675 - Biomed Res Int. 2014;2014:780521 22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11 19070389 - J Hepatol. 2009 Feb;50(2):358-69 15059927 - Carcinogenesis. 2004 Aug;25(8):1535-42 27021847 - Free Radic Res. 2016 Jul;50(7):732-43 24744378 - Science. 2014 Apr 18;344(6181):310-3 25888444 - J Hematol Oncol. 2015 Mar 28;8:30 16565491 - Am J Pathol. 2006 Apr;168(4):1155-68 18820947 - J Cancer Res Clin Oncol. 2009 Apr;135(4):515-22 24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26 25167886 - J Hematol Oncol. 2014 Aug 29;7:63 23480766 - Asian Pac J Cancer Prev. 2012;13 Suppl:65-9 24140396 - Gastroenterology. 2013 Dec;145(6):1215-29 23417858 - Tumour Biol. 2013 Jun;34(3):1579-88 23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21 9201097 - Dig Dis Sci. 1997 Jun;42(6):1290-4 25356314 - Biomark Res. 2014 Oct 22;2:19 25991924 - Genome Med. 2015 May 13;7(1):39 9527063 - Ann Surg. 1998 Mar;227(3):398-404 24297921 - Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20693-8 17461449 - World J Gastroenterol. 2007 Mar 14;13(10 ):1561-8 25516643 - World J Gastroenterol. 2014 Dec 14;20(46):17324-9 23962981 - Sci Signal. 2013 Aug 20;6(289):re5 27563706 - Cell Mol Life Sci. 2017 Feb;74(4):607-616 21086164 - Dig Dis Sci. 2011 Jun;56(6):1693-701 24723426 - Eur J Immunol. 2014 Jul;44(7):2085-95 23333246 - Cell Signal. 2013 Apr;25(4):961-9 21769904 - Hepatology. 2011 Nov;54(5):1679-89 24631641 - Int J Biochem Cell Biol. 2014 Jul;52:184-91 24843008 - Elife. 2014 Apr 29;3:e01776 16606333 - Biol Chem. 2006 Apr;387(4):365-72 |
References_xml | – volume: 9 start-page: 57 year: 2016 ident: 348_CR45 publication-title: J Hematol Oncol doi: 10.1186/s13045-016-0288-8 – volume: 35 start-page: 3376 year: 2016 ident: 348_CR49 publication-title: Oncogene doi: 10.1038/onc.2015.396 – volume: 2014 start-page: 1414 year: 1843 ident: 348_CR55 publication-title: Biochim Biophys Acta – volume: 135 start-page: 515 year: 2009 ident: 348_CR67 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-008-0483-2 – ident: 348_CR64 doi: 10.1007/s00018-016-2339-2 – volume: 65 start-page: 1464 year: 2013 ident: 348_CR63 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2013.07.034 – volume: 178 start-page: 3893 year: 2007 ident: 348_CR34 publication-title: J Immunol doi: 10.4049/jimmunol.178.6.3893 – volume: 282 start-page: 9 year: 2015 ident: 348_CR12 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2014.10.022 – volume: 23 start-page: 3278 year: 2014 ident: 348_CR43 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddu040 – volume: 8 start-page: 30 year: 2015 ident: 348_CR38 publication-title: J Hematol Oncol doi: 10.1186/s13045-015-0129-1 – volume: 7 start-page: 63 year: 2014 ident: 348_CR44 publication-title: J Hematol Oncol doi: 10.1186/s13045-014-0063-7 – volume: 15 start-page: S7 issue: Suppl 9 year: 2014 ident: 348_CR14 publication-title: BMC Genomics doi: 10.1186/1471-2164-15-S9-S7 – volume: 119 start-page: 1067 year: 2006 ident: 348_CR6 publication-title: Int J Cancer doi: 10.1002/ijc.21893 – volume: 42 start-page: 1290 year: 1997 ident: 348_CR51 publication-title: Dig Dis Sci doi: 10.1023/A:1018822628096 – volume: 333 start-page: 213 year: 2013 ident: 348_CR57 publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.01.033 – volume: 49 start-page: 1603 year: 2010 ident: 348_CR7 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.09.006 – volume: 52 start-page: 184 year: 2014 ident: 348_CR32 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2014.02.022 – volume: 24 start-page: 4085 year: 2004 ident: 348_CR24 publication-title: Anticancer Res – volume: 7 start-page: 90 year: 2014 ident: 348_CR23 publication-title: J Hematol Oncol doi: 10.1186/s13045-014-0090-4 – volume: 145 start-page: 1215 year: 2013 ident: 348_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.10.013 – volume: 33 start-page: 103 year: 2014 ident: 348_CR41 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-014-0103-8 – volume: 44 start-page: 2085 year: 2014 ident: 348_CR10 publication-title: Eur J Immunol doi: 10.1002/eji.201344126 – volume: 50 start-page: 732 year: 2016 ident: 348_CR37 publication-title: Free Radic Res doi: 10.3109/10715762.2016.1172071 – volume: 110 start-page: 20693 year: 2013 ident: 348_CR58 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1310201110 – volume: 6 start-page: 24141 year: 2016 ident: 348_CR29 publication-title: Sci Rep doi: 10.1038/srep24141 – volume: 20 start-page: 11630 year: 2014 ident: 348_CR9 publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i33.11630 – volume: 20 start-page: 17324 year: 2014 ident: 348_CR66 publication-title: World J Gastroentero doi: 10.3748/wjg.v20.i46.17324 – volume: 2012 start-page: 630543 year: 2012 ident: 348_CR1 publication-title: Int J Hepatol doi: 10.1155/2012/630543 – volume: 3 start-page: e1776 year: 2014 ident: 348_CR11 publication-title: Elife doi: 10.7554/eLife.01776 – volume: 227 start-page: 398 year: 1998 ident: 348_CR50 publication-title: Ann Surg doi: 10.1097/00000658-199803000-00012 – volume: 38 start-page: 5366 year: 2010 ident: 348_CR27 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq285 – volume: 76 start-page: 2327 year: 2016 ident: 348_CR46 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-1443 – volume: 27 start-page: 370 year: 2015 ident: 348_CR30 publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.02.004 – volume: 1 start-page: 58 year: 2012 ident: 348_CR40 publication-title: Transl Gastrointest Cancer – volume: 14 start-page: 184 year: 2015 ident: 348_CR56 publication-title: Mol Cancer doi: 10.1186/s12943-015-0458-2 – volume: 56 start-page: 1693 year: 2011 ident: 348_CR18 publication-title: Dig Dis Sci doi: 10.1007/s10620-010-1481-1 – volume: 6 start-page: e5 year: 2013 ident: 348_CR25 publication-title: Sci Signal doi: 10.1126/scisignal.6288er5 – volume: 194 start-page: 487 year: 2016 ident: 348_CR65 publication-title: Lung doi: 10.1007/s00408-016-9879-y – volume: 8 start-page: 50 year: 2015 ident: 348_CR22 publication-title: J Hematol Oncol doi: 10.1186/s13045-015-0146-0 – volume: 25 start-page: 1535 year: 2004 ident: 348_CR3 publication-title: Carcinogenesis doi: 10.1093/carcin/bgh157 – volume: 529 start-page: 307 year: 2016 ident: 348_CR2 publication-title: Nature. doi: 10.1038/nature17039 – volume: 54 start-page: 1679 year: 2011 ident: 348_CR26 publication-title: Hepatology doi: 10.1002/hep.24563 – volume: 36 start-page: 423 year: 2015 ident: 348_CR61 publication-title: Cell Physiol Biochem doi: 10.1159/000430109 – volume: 52 start-page: 101 year: 2013 ident: 348_CR39 publication-title: Mol Cell doi: 10.1016/j.molcel.2013.08.027 – volume: 287 start-page: 26302 year: 2012 ident: 348_CR60 publication-title: J Biol Chem doi: 10.1074/jbc.M112.342113 – volume: 21 start-page: 29 year: 2014 ident: 348_CR52 publication-title: Curr Opin Hematol doi: 10.1097/MOH.0000000000000002 – volume: 20 start-page: 932 year: 2011 ident: 348_CR13 publication-title: Exp Dermatol doi: 10.1111/j.1600-0625.2011.01359.x – volume: 98 start-page: 8798 year: 2001 ident: 348_CR35 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.161272598 – volume: 25 start-page: 961 year: 2013 ident: 348_CR48 publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.01.007 – volume: 13 start-page: 1561 year: 2007 ident: 348_CR53 publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i10.1561 – volume: 18 start-page: 3849 year: 2012 ident: 348_CR19 publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i29.3849 – volume: 49 start-page: 90 year: 2016 ident: 348_CR36 publication-title: Cell Prolif doi: 10.1111/cpr.12228 – volume: 13 start-page: 65 issue: Suppl year: 2012 ident: 348_CR21 publication-title: Asian Pac J Cancer Prev – volume: 168 start-page: 1155 year: 2006 ident: 348_CR54 publication-title: Am J Pathol doi: 10.2353/ajpath.2006.050204 – volume: 2014 start-page: 780521 year: 2014 ident: 348_CR28 publication-title: Biomed Res Int – volume: 2014 start-page: 149185 year: 2014 ident: 348_CR47 publication-title: J Immunol Res doi: 10.1155/2014/149185 – volume: 27 start-page: 378 year: 2008 ident: 348_CR17 publication-title: Oncogene doi: 10.1038/sj.onc.1210648 – volume: 50 start-page: 358 year: 2009 ident: 348_CR15 publication-title: J Hepatol doi: 10.1016/j.jhep.2008.09.015 – volume: 309 start-page: F901 year: 2015 ident: 348_CR33 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00290.2015 – volume: 61 start-page: 130 year: 2012 ident: 348_CR8 publication-title: Parasitol Int doi: 10.1016/j.parint.2011.06.011 – volume: 34 start-page: 1579 year: 2013 ident: 348_CR20 publication-title: Tumour Biol doi: 10.1007/s13277-013-0688-0 – volume: 7 start-page: 39 year: 2015 ident: 348_CR31 publication-title: Genome Med doi: 10.1186/s13073-015-0162-2 – volume: 10 start-page: 1647 year: 2004 ident: 348_CR62 publication-title: Curr Pharm Des doi: 10.2174/1381612043384727 – volume: 387 start-page: 365 year: 2006 ident: 348_CR5 publication-title: Biol Chem doi: 10.1515/BC.2006.049 – volume: 279 start-page: 3159 year: 2012 ident: 348_CR59 publication-title: FEBS J doi: 10.1111/j.1742-4658.2012.08694.x – volume: 344 start-page: 310 year: 2014 ident: 348_CR42 publication-title: Science doi: 10.1126/science.1251456 – volume: 2 start-page: 19 year: 2014 ident: 348_CR16 publication-title: Biomark Res doi: 10.1186/2050-7771-2-19 – reference: 23354591 - Cancer Lett. 2013 Jun 10;333(2):213-21 – reference: 24843008 - Elife. 2014 Apr 29;3:e01776 – reference: 20423907 - Nucleic Acids Res. 2010 Sep;38(16):5366-83 – reference: 22724089 - Transl Gastrointest Cancer. 2012 Apr 1;1(1):58-70 – reference: 21086164 - Dig Dis Sci. 2011 Jun;56(6):1693-701 – reference: 25968300 - Cell Physiol Biochem. 2015;36(2):423-34 – reference: 27021847 - Free Radic Res. 2016 Jul;50(7):732-43 – reference: 26400545 - Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F901-13 – reference: 24631641 - Int J Biochem Cell Biol. 2014 Jul;52:184-91 – reference: 25991924 - Genome Med. 2015 May 13;7(1):39 – reference: 9527063 - Ann Surg. 1998 Mar;227(3):398-404 – reference: 26726846 - Cell Prolif. 2016 Feb;49(1):90-101 – reference: 17621267 - Oncogene. 2008 Jan 10;27(3):378-86 – reference: 25167886 - J Hematol Oncol. 2014 Aug 29;7:63 – reference: 23480766 - Asian Pac J Cancer Prev. 2012;13 Suppl:65-9 – reference: 11447290 - Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8798-803 – reference: 24275689 - Curr Opin Hematol. 2014 Jan;21(1):29-36 – reference: 15059927 - Carcinogenesis. 2004 Aug;25(8):1535-42 – reference: 24055342 - Mol Cell. 2013 Oct 10;52(1):101-12 – reference: 23917144 - Free Radic Biol Med. 2013 Dec;65:1464-72 – reference: 20840865 - Free Radic Biol Med. 2010 Dec 1;49(11):1603-16 – reference: 26921327 - Cancer Res. 2016 Apr 15;76(8):2327-39 – reference: 17461449 - World J Gastroenterol. 2007 Mar 14;13(10 ):1561-8 – reference: 24703882 - Biochim Biophys Acta. 2014 Jul;1843(7):1414-26 – reference: 21913998 - Exp Dermatol. 2011 Nov;20(11):932-7 – reference: 24140396 - Gastroenterology. 2013 Dec;145(6):1215-29 – reference: 25206269 - World J Gastroenterol. 2014 Sep 7;20(33):11630-40 – reference: 24297921 - Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20693-8 – reference: 25888444 - J Hematol Oncol. 2015 Mar 28;8:30 – reference: 24488769 - Hum Mol Genet. 2014 Jun 15;23(12):3278-88 – reference: 25491133 - J Hematol Oncol. 2014 Dec 10;7:90 – reference: 22685290 - J Biol Chem. 2012 Jul 27;287(31):26302-11 – reference: 25447409 - Toxicol Appl Pharmacol. 2015 Jan 1;282(1):9-19 – reference: 16606333 - Biol Chem. 2006 Apr;387(4):365-72 – reference: 22876037 - World J Gastroenterol. 2012 Aug 7;18(29):3849-61 – reference: 24901008 - J Immunol Res. 2014;2014:149185 – reference: 25516643 - World J Gastroenterol. 2014 Dec 14;20(46):17324-9 – reference: 22776265 - FEBS J. 2012 Sep;279(17):3159-65 – reference: 24757675 - Biomed Res Int. 2014;2014:780521 – reference: 17339489 - J Immunol. 2007 Mar 15;178(6):3893-902 – reference: 26455324 - Oncogene. 2016 Jun 30;35(26):3376-86 – reference: 27063004 - Sci Rep. 2016 Apr 11;6:24141 – reference: 15134562 - Curr Pharm Des. 2004;10(14):1647-52 – reference: 26791721 - Nature. 2016 Jan 21;529(7586):307-15 – reference: 18820947 - J Cancer Res Clin Oncol. 2009 Apr;135(4):515-22 – reference: 27439973 - J Hematol Oncol. 2016 Jul 21;9(1):57 – reference: 27113373 - Lung. 2016 Aug;194(4):487-99 – reference: 27563706 - Cell Mol Life Sci. 2017 Feb;74(4):607-616 – reference: 16565491 - Am J Pathol. 2006 Apr;168(4):1155-68 – reference: 19070389 - J Hepatol. 2009 Feb;50(2):358-69 – reference: 25522241 - BMC Genomics. 2014;15 Suppl 9:S7 – reference: 24744378 - Science. 2014 Apr 18;344(6181):310-3 – reference: 21769904 - Hepatology. 2011 Nov;54(5):1679-89 – reference: 23333246 - Cell Signal. 2013 Apr;25(4):961-9 – reference: 21994887 - Int J Hepatol. 2012;2012:630543 – reference: 23962981 - Sci Signal. 2013 Aug 20;6(289):re5 – reference: 24723426 - Eur J Immunol. 2014 Jul;44(7):2085-95 – reference: 15736456 - Anticancer Res. 2004 Nov-Dec;24(6):4085-9 – reference: 25356314 - Biomark Res. 2014 Oct 22;2:19 – reference: 25471741 - J Exp Clin Cancer Res. 2014 Dec 04;33:103 – reference: 25966845 - J Hematol Oncol. 2015 May 14;8:50 – reference: 25759022 - Cancer Cell. 2015 Mar 9;27(3):370-81 – reference: 21704729 - Parasitol Int. 2012 Mar;61(1):130-5 – reference: 23417858 - Tumour Biol. 2013 Jun;34(3):1579-88 – reference: 16570287 - Int J Cancer. 2006 Sep 1;119(5):1067-72 – reference: 9201097 - Dig Dis Sci. 1997 Jun;42(6):1290-4 – reference: 26536864 - Mol Cancer. 2015 Nov 04;14:184 |
SSID | ssj0061920 |
Score | 2.5342343 |
Snippet | Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about lncRNAs in... Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about... BACKGROUNDLong non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known about... Abstract Background Long non-coding RNAs (lncRNAs) are known to play important roles in different cell contexts, including cancers. However, little is known... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 117 |
SubjectTerms | Biomarkers Cell adhesion & migration Cell cycle Cell Line, Tumor Cell Movement ceRNA Cholangiocarcinoma Cholangiocarcinoma - etiology Cholangiocarcinoma - genetics Cholangiocarcinoma - pathology Disease Disease Progression Hematology Humans Inflammation Inflammation response Interleukin-6 - genetics MicroRNAs Migration and invasion Neoplasm Invasiveness Oncology Oxidative stress Oxidative Stress - genetics Pathogenesis Proteins Receptors, CXCR4 - genetics RNA, Long Noncoding - metabolism RNA, Long Noncoding - physiology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLaZs-nKZBhZ5KTGRblqxjGhKWkuRQupCbkPVIDV1tyG5C8gP6vzsjeZdsKemlYIOxRpYsjWbm02OGkE_GBS-l68FyE23Jq74rDeg5nBKQVoFINB6B4tm5mEz514v24kGoL9wTlt0D54Y7YMH5WnoHMCRwBR8zgMG9r_oAhkDv0zFf0HkrMJVlMKKC1Rpm1YmDRYULggCbAT03vCvZhhZKzvr_ZmH-uVHygeY5eUGejyYjPcxVfUme-PiKPD0bF8W3ya_TaL-dHy7opFLUREcn09OjfYonFm7BknS0v6fzu8ElF980Hw7Zp1dpH56nOHNPZ8Nl5oSUf4i3BifR4IEm7BsvB1B511DcfGboGNqHGsgL5dKZwfBdr8n05Pj70aQcoyuUVtRqWYbW1XAF14ZgoVG85cxY2dZc9g1jgRvAhjY0LgjLhLVB9aZSluMdFGR5Q7biPPp3hHIgbBouuhbQXMDTsgFQiwmdk77mvioIW7W2tqPrcYyA8VMnCNIJnTtI43Yz7CDNCvJ5neUq-914jPgLduGaEF1mpxfASHpkJP0vRirI7ooB9DiOFxoEHgDEGiRbQT6uk2EEYueY6Oc3mQYgChdA8zbzy7omteyY6mRTELnBSRtV3UyJw4_k5RssuUaJdud__Nt78qxG5sfp8GaXbC2vb_wHMKaW_V4aN78BnhAdXg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Za9wwEBYhhdKX0rtu06BCn0rc-pAl66GUJCQsJZuH0oW8GVnH1pCV091NSH5A_3dn5INuWAI2GHsGC82MZj4dM4R8UsZZIUwNkRsvYpbWZazAz-GUgNAShkRlEShOz_lkxn5cFBc7ZChv1Xfgaiu0w3pSs-Xll9s_d9_B4L8Fgy_511WKy30AigEb56yMAcE_AscksKDBlI2LCggVhoXNrWwbrilk8N8Wdt7fPfmfOzp9Rp72cSQ97AT_nOxY_4I8nvYr5S_J3zOvf54frugklVR5Qyezs-MDiscYbiC8NLS-o-1tY0Leb9qdGDmgV2FznqU4nU8XzbxTj8Df-BuFM2vwQEOv-XkDfnAJv2sXivb1fqgCXvgvXSis6fWKzE5Pfh1P4r7kQqx5JtexK0wGlzOFcxo6xWqWKC2KjIk6TxLHFABG7XLjuE641k7WKpWa4e0ksLwmu7719i2hDAjznPGyAIjn8AitAyijXGmEzZhNI5IMvV3pPh85lsW4rAIuKXnVCajCPWgooCqJyOeR5apLxvEQ8RGKcCTEPNrhRbucV71ZVokzNhPWAMh1TIKqqkTm1qa1gzCztmVE9gYFqAbdrGAUBNSYwXAXkY_jZzBLFI7ytr3uaAC3MA40bzp9GVuSiTKRpcgjIjY0aaOpm1988zuk_obwLpe8ePdws96TJxmqNc5-53tkd728th8gdlrX-8Ei_gHPsxbx priority: 102 providerName: Scholars Portal |
Title | LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27809873 https://www.proquest.com/docview/1836252042 https://www.proquest.com/docview/1836729462 https://pubmed.ncbi.nlm.nih.gov/PMC5093965 https://doaj.org/article/0fde27ed094f4941ba093ee1bf423be8 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9swEBZbC2Nfxt7nrQsa7NOoqV9kyf400tISQhNGt0C-GVkvmWGxsyQt2w_Y_96drHhNGYU4NvYJC98j6Z6TdEfIR6mtEUJXYLnxLGRxlYcSxjl0CQhVQJcoDRLFyZSPZmw8z-be4bbxyyp3faLrqHWr0Ed-AtADUz0BjH1e_QwxaxTOrvoUGg_JIYYuQ1SLeU-4kBvsZjLjnJ9sYpwWBPIMHDpleRjtjUUuZP__7My7yyVvjT8XT8kTbzjSYafpZ-SBaZ6TRxM_Nf6C_Lls1NV0uKGjuKCy0XQ0uzw7prhv4QbsSU2r37T9VWsX6Jt2W0SO6cqtxjMU_fd0WS86PLjydXMj0ZUGF9Qx4GZRw8C3hte1S0l9gh8qoSy8ly4lJvF6SWYX59_ORqHPsRAqnhTb0GY6gZ_VmbUKPopRLJJKZAkTVRpFlklgiMqm2nIVcaVsUcm4UAwPW0CRV-SgaRvzhlAGgmnKeJ4Bp7O4Z9YCd5E218IkzMQBiXZfu1Q-ADnmwfhROiKS87JTUImLzlBBZRSQT32RVRd94z7hU1RhL4iBs92Ndr0ofTssI6tNIowGVmtZAdiUUZEaE1cW7MrK5AE52gGg9K15U_7DXkA-9I-hHaJyZGPa604GiArjIPO6w0tfk0TkUZGLNCBiD0l7Vd1_0tTfXaxvsOfSgmdv76_WO_I4QVijuzs9Igfb9bV5D8bSthq4FjEgh8Ph-OsYzqfn0y9XA-d6gP8Jy_8CjMkY8Q |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxOcIDDASvKBFcxwnTh4QGoOpY20f0Cr1LTj-KJFoUtpusD-Af4e_kbt8QRHa26RUippzbOXufPfz2XeEvFTGWSlNDp5bHPkiyBNfgZ3DJQGpU5gSlUWgOBrHg4n4OI2mW-RXdxYGt1V2c2I9UZtK4xr5PogeuOocZOzt4puPVaMwutqV0GjE4sRefAfItnpz_B74-4rzow-nhwO_rSrg65ina99FhsPlTOScDkVitWBKy4gLmYeMOaEAE2kXGhdrFmvt0lwFqRb4cyk0gfdeI9fB8DIEe3LaAzzEIl3kNEji_VWAYUgA64DZoSOfbdi-ukTA__zaf7dn_mXvju6Q262jSg8aybpLtmx5j9wYtaH4--TnsNSfxgcrOghSqkpDB5Ph4R7FcxLn4L8aml_Q6kdh6sTitDmSskcX9e4_SzFeQOfFrJG_un1RnitcuoMbWiPuclaAoV1Cd9Vc0bagEFXQFvqlc4VFwx6QyZV8_Ydku6xK-4hQAYRhKOIkAgzp8IyuA6ykXGKk5cIGHmHd1850m_Ac6258zWrgk8RZw6AMN7khgzLmkdd9k0WT7eMy4nfIwp4QE3XXf1TLWdbqfcacsVxaAyjaiRR0QbE0tDbIHfixuU08stsJQNbOHqvsj6x75EX_GPQemaNKW501NACMRAw0O4289CPhMmFpIkOPyA1J2hjq5pOy-FLnFgf_MUzj6PHlw3pObg5OR8NseDw-eUJucRRxXGoPd8n2enlmn4Kjts6f1dpByeerVsffj1ZS1Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNAs+H19+and+HULC%2C+activated+by+oxidative+stress%2C+promote+cell+migration+and+invasion+in+cholangiocarcinoma+through+a+ceRNA+manner&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Wen-Tao%2C+Wang&rft.au=Ye%2C+Hua&rft.au=Pan-Pan%2C+Wei&rft.au=Bo-Wei%2C+Han&rft.date=2016-11-03&rft.pub=BioMed+Central&rft.eissn=1756-8722&rft.volume=9&rft_id=info:doi/10.1186%2Fs13045-016-0348-0&rft.externalDocID=4239632311 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon |